Skip to content

Effect of Varmam Therapy and Siddha Formulations in the management of Sagana Vatham.

Study on Therapeutic effect of Varmam Therapy and Siddha Formulations (Amukkara Choornam Plain with Kungiliya parpam) in the management of Sagana Vatham (Cervical Spondylosis) - Patients reporting at Ayothidoss Pandithar Hospital of National Institute of Siddha, Chennai. An open, Non-randomized, Double Armed, Single Centric, Clinical Trial. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060644
Enrollment
148
Registered
2023-12-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis Health Condition 2: M478- Other spondylosis

Interventions

Intervention1: Varmam theraphy and Siddha formulations in the management of sagana vatham: Varmam Therapy and Siddha Formulations (Amukkara Choornam plain with kungiliya parpam) in the management of S
15-20minutes no of sittings:3days once for 48 days (16 sittings) Trial medicines:Amukkara choornam Dose:3gms Adjuvant:Milk Kungiliya parpam Dose:260mg(2kundri) Adjuvant:Milk Control Intervention1: NIL

Sponsors

Dr L Janani Saravana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pain in the Cervical region. With or without numbness. Radiating pain in upper limb. VAS Scores more than 3 points at entry. XRAY - AP and lateral view corresponds to cervical spondylosis.

Exclusion criteria

Exclusion criteria: Pregnant Women. TB in Cervical spine. Cardiac Disease. Fracture in Cervical vertebrae. Obese patients. Malignancy. Lactating women. Any other serious illness.

Design outcomes

Primary

MeasureTime frame
Visual Analog ScaleTimepoint: Visual Analog Scale Duration:8weeks

Secondary

MeasureTime frame
Neck Disability IndexTimepoint: 0-4: No disability 5-14: Mild disability 15-24: Moderate disability 25-34: Severe disability 35-50: Complete disability Duration:8weeks

Countries

India

Contacts

Public ContactDr L Janani Saravana

National Institute of Siddha

njmuthukumar@gmail.com9444206843

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026